Vol 9, No 1 (2013)

January/February

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Articles

Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatment
Ryan A. Black, PhD, Kimberlee J. Trudeau, PhD, Theresa A. Cassidy, MPH, Simon H. Budman, PhD, Stephen F. Butler, PhD
PDF
5-17
Preliminary data on a new opioid risk assessment measure: The Brief Risk Interview
Ted Jones, PhD, Todd Moore, PhD
PDF
19-27
Hypoglycemia during rapid methadone dose escalation
Natalie Moryl, MD, Joan Pope, NP, Eugenie Obbens, MD, PhD
PDF
29-34
Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects
Jatinder Mohan Chawla, MD, Hemraj Pal, MD, Rakesh Lal, MD, Raka Jain, PhD, Nina Schooler, PhD, Yatan Pal Singh Balhara, MD
PDF
35-41
Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain
Srinivas Nalamachu, MD, Donna Ruck, ARNP, Rahul Nalamasu, Sam Fasbinder, Ritvik Bansal
PDF
43-49
Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: Pooled analysis of randomized studies
Sanjay Merchant, PhD, David Provenzano, MD, Samir Mody, PharmD, MBA, Kai Fai Ho, PhD, Mila Etropolski, MD
PDF
51-61
Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome
Suzannah Kokotajlo, PharmD, Christine A. Robinson, PharmD, Amy Presti, MD, MSCR
PDF
62-70

Review Articles

Review article. Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management
Aarti Singla, MD, Paul Sloan, MD
PDF
71-80